Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Biosynthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel biosynthesis pathway for 2,4-DHB reduces costs and enhances supply chain reliability for pharmaceutical and nutrition intermediate manufacturing globally.
Novel enzymatic route for S-nicotine production offers high purity and cost efficiency for pharmaceutical intermediate supply chains globally via green biosynthesis.
Deep dive into CN110607335B for NAD biosynthesis. Explore cost reduction in pharmaceutical intermediates manufacturing and supply chain advantages.
Novel thiostrepton analogue with enhanced solubility and activity via mutant biosynthesis. Reliable supply chain for pharmaceutical intermediates and cost reduction.
Novel chorismic acid pathway for NAD production. Reduces precursor costs and enhances supply chain reliability for global pharmaceutical manufacturers.
Patent CN118791350B reveals enzymatic synthesis of novel antibacterial diterpenoids. Offers green manufacturing and supply chain reliability for pharmaceutical intermediates.